LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
MAT
Mattel, Inc.
MAT has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MAT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
MAT's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.2x | $15.53 | — |
| Cheap | 9.4x | $15.95 | +2.7% |
| Forward | 12x | $15.53 | — |
| Fair | 13x | $21.78 | +40% |
| Expensive | 32x | $53.59 | +245% |
Historical ranges are pointers, not guarantees.
MAT's PE is in its cheap range at 9.2x. On analysts' estimates for next year's earnings, today's price would be 12x, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MAT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect MAT's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.34 | -21% |
| Q3 2026 | $1.69 | +28% |
| Q2 2026 | $1.34 | -12% |
| Q1 2026 | $1.56 | +1.3% |
| Q4 2025 | $1.24 | -22% |
| Q3 2025 | $1.32 | -17% |
| Q2 2025 | $1.53 | +68% |
| Q1 2025 | $1.54 | +88% |
| Q4 2024 | $1.58 | +163% |
MAT has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +4.1% |
| Q2 2026 | $1.1B | +10% |
| Q1 2026 | $862.2M | +4.3% |
| Q4 2025 | $1.8B | +7.3% |
| Q3 2025 | $1.7B | -5.9% |
| Q2 2025 | $1B | -5.7% |
| Q1 2025 | $826.6M | +2.1% |
| Q4 2024 | $1.6B | +1.6% |
MAT's revenue has grown year over year for four quarters in a row: $1.8B last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +4.5 points |
| Q2 2026 | 1% | -6.7 points |
| Q1 2026 | -12% | -5.5 points |
| Q4 2025 | 8% | -1.6 points |
| Q3 2025 | 22% | -4.6 points |
| Q2 2025 | 7.7% | 0 points |
| Q1 2025 | -6.4% | -2 points |
| Q4 2024 | 9.6% | +1 points |
MAT has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $50.7M | +23% |
| Q2 2026 | -$221.5M | +$101.8M |
| Q1 2026 | -$67.8M | -1799% |
| Q4 2025 | $760.8M | -8.9% |
| Q3 2025 | $41.1M | -48% |
| Q2 2025 | -$323.3M | -$53.1M |
| Q1 2025 | $4M | -81% |
| Q4 2024 | $835.5M | -9.6% |
MAT has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -2.1M shares |
| 1 year | -9.8% | -31.3M shares |
| 3 years | -20% | -70.7M shares |
| 5 years | -19% | -67.4M shares |
| Available history | -18% | -61.5M shares |
MAT has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.4M |
| Q2 2026 | $100M |
| Q1 2026 | $200M |
| Q4 2025 | $187.5M |
| Q3 2025 | $202.5M |
| Q2 2025 | $50M |
| Q1 2025 | $160M |
| Q4 2024 | $131.7M |
MAT spent $496M buying back its own shares over the past year, down 8.9% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 3.0x | Moderate |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.1x | Healthy |
MAT's net debt is about 2.5 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 60.3 | Neutral |
MAT's weekly RSI is 51 (neutral) and its Stochastic is 60 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MAT PE vs Consumer Cyclical Sector
| Metric | MAT | Sector median | Relative |
|---|---|---|---|
| PE | 9.2x | 18x | 49% below |
| PE % | 14 | 47 | 33 pts below |
MAT is trading at 9.2x earnings, a 49% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 0.7% below |
| 20 week MA | $14.8 | 4.6% above |
| 50 week MA | $16.1 | 3.8% below |
| 100 week MA | $17.4 | 11% below |
| 200 week MA | $18.2 | 15% below |
MAT has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.8 | $17.5 | +27% |
| 2021 | $17.5 | $20.7 | +18% |
| 2022 | $20.7 | $16.9 | -18% |
| 2023 | $16.9 | $18.9 | +12% |
| 2024 | $18.9 | $18.0 | -4.9% |
| 2025 | $18.0 | $20.3 | +13% |
| 2026 YTD | $20.3 | $15.5 | -23% |
MAT has the edge over LCID on returns for 2026, with the stronger performance.